• SENSEX 76,718.56
    148.21 (+0.19%)
  • BANKNIFTY 57,172.00
    -237.60 (--0.41%)
  • Power Fin.Corpn.
    351.60 486.45(%)
  • Netweb Technol.
    5,347.65 5,810.00(%)
  • Antelopus Selan
    1,035.95 951.45(%)
  • IFCI
    101.60 99.45(%)
  • HDFC Bank
    712.75 1,020.35(%)
  • Godrej Consumer
    859.50 891.10(%)
  • Max Healthcare
    988.00 903.50(%)
  • Milky Mist Dairy
    268.75 255.10(%)
  • Solar Industries
    21,569.40 20,760.15(%)
  • Elgi Equipments
    629.30 643.30(%)
  • Energy InfrTrust
    74.25 102.00(%)
  • Ather Energy
    1,630.00 481.25(%)
  • Bharat Dynamics
    1,266.45 1,655.25(%)
  • Jyoti CNC Auto.
    999.00 1,055.00(%)
  • Welspun Corp
    2,675.00 2,593.15(%)
  • Divi's Lab.
    9,277.55 9,296.00(%)
  • Anant Raj
    634.60 744.10(%)
  • Coal India
    428.40 490.90(%)
  • RBL Bank
    409.00 397.95(%)
  • Multi Comm. Exc.
    3,180.35 1,496.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Dishman Carbogen Amcis Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67697.0
  • ISIN : INE385W01011
176.85 -5 (-2.74%)
  • As on 03 Sep 2026 (EOD)

  • Today’s Low

    174.82

  • Today’s High

    183.62

  • Open

    182.00

  • Perv Close

    181.83

  • 52W Low

    128.50

  • 52W High

    321.95

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2,772.71

  • Div & Yield %

    0.00

  • Book Value(₹)

    247.62

  • Debt-Equity Ratio

    -2.74

  • AGM Date

    02-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    2,772.71

  • RONW (%)

    -2.68

  • ROCE (%)

    -0.03

Score Board

  • Equity (₹ in Cr.)

    31.36

  • BV (₹)

    247.60

  • Sales( ₹ in Cr.)

    231.56

  • NP (in Cr.)

    -38.40

  • NP Var(%)

    -243.0

  • Div%

    0.0

  • CPS (₹)

    1.50

  • EPS (₹)

    -2.40

  • Traded Value (₹ in Lakhs)

    2,775.06

  • 52 Week High

    321.95

  • 52 Week Low

    128.50

  • Price BSE

    177.0

  • Price NSE

    177.00

  • Market Capital( in Cr.)

    2,775.06

  • P/C Ratio

    114.80

  • P/E Ratio

    -72.30

  • Price Vs.BV

    -2.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 399.84 327.35 402.55 306.61 200.32 580.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 399.84 327.35 402.55 306.61 200.32 580.74
Other Income 32.98 63.05 52.16 60.39 66.15 69.55
Stock Adjustments -14.00 -8.27 -8.00 7.70 -22.54 -19.96
Total Income 418.82 382.13 446.71 374.70 243.93 630.33
EXPENDITURE :            
Raw Materials 117.01 107.70 163.35 107.11 75.04 180.15
Power and Fuel Cost 32.16 28.71 33.07 24.83 12.78 35.27
Employee Cost 90.15 91.54 86.13 79.04 58.23 88.87
Other Manufacturing Expenses 21.69 27.94 31.21 22.57 18.95 26.56
Selling and Administration Expenses 50.59 46.30 52.54 46.03 28.90 42.84
Miscellaneous Expenses 2.45 13.14 22.49 2.21 43.20 13.51
Employee Benefit Expenses 90.15 91.54 86.13 79.04 58.23 88.87
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 314.05 315.33 388.79 281.79 237.10 387.20
Operating Profit 104.77 66.80 57.92 92.91 6.83 243.13
Interest 70.40 68.19 57.92 37.23 34.17 47.02
Gross Profit 34.37 -1.39 0.00 55.68 -27.34 196.11
Depreciation 65.20 101.61 96.20 140.07 141.35 140.65
Profit Before Tax -30.83 -103.00 -96.20 -84.39 -168.69 55.46
Current Tax 0.00 11.06 0.00 0.00 17.97 9.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -20.96 -37.65 -37.33 -52.84 46.15 7.64
Reported Net Profit -9.87 -76.41 -58.87 -31.55 -232.81 38.52
Extraordinary Items 1.31 -1.02 -2.79 -0.79 2.52 -4.06
Adjusted Net Profit -11.18 -75.39 -56.08 -30.76 -235.33 42.58
Adjustment below Net Profit 0.49 -0.07 0.33 0.10 -0.51 -0.27
P & L Balance brought forward -310.93 -234.45 -175.91 -144.47 88.85 53.83
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 3.23
P & L Balance carried down -320.31 -310.93 -234.45 -175.92 -144.47 88.85
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.63 -4.87 -3.75 -2.01 -14.85 2.46
Earnings Per Share(Adj)-Unit Curr -0.63 -4.87 -3.75 -2.01 -14.85 2.46
Book Value 257.05 258.46 262.39 269.88 298.13 305.66
Book Value(Adj)-Unit Curr 257.05 258.46 262.39 269.88 298.13 305.66

Shareholding Pattern

  • Promoter Group

    59.32%

  • Public Share Holding

    40.68%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 93,002,442 59.32 93,002,442 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,000 0.00 5,000 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 93,007,442 59.32 93,007,442 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 10,758,633 6.86 10,758,633 51
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,217,972 1.41 2,217,972 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,019,900 0.65 1,019,900 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,996,505 8.93 13,996,505 60
2] Non Institution
Bodies Corporate 2,392,068 1.53 2,392,068 245
Clearing Members 72,058 0.05 72,058 24
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,671,143 1.07 1,671,143 1,026
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,684,556 1.07 1,684,556 1,306
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 19,351,106 12.34 19,351,106 31
Individuals holding nominal share capital up to Rs. 1 lakh 23,480,176 14.98 23,479,491 46,694
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 9,734 0.01 9,734 3
Others 29,216 0.02 29,216 2
Sub Total 49,779,148 31.75 49,778,463 49,365
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 156,783,095 100.00 156,782,410 49,430

Company Background

Dishman Carbogen Amcis LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Dishman Carbogen Amcis Ltd
  • BSE Code : 67697.0
  • ISIN : INE385W01011

  • Incorporation Year

    2007

  • Registered Office

    Dishman Corporate House
    Iscon-Bopal Road Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    91-2717-400102/124

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Shrima Dave

  • Auditor

    T R Chadha & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Dishman Carbogen Amcis Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Dishman Carbogen 177.00 432.82 399.84 -42.75 0.00
Abbott India 26,025.15 7,217.19 6,929.05 34.25 43.78
Astrazeneca Phar 6,870.25 2,304.07 2,275.58 101.26 27.86
Glaxosmi. Pharma 2,946.60 3,932.76 3,790.20 47.07 58.17
Novartis India 1,602.15 398.23 356.27 40.46 16.64
Cipla 1,413.15 20,102.60 18,979.95 37.14 13.88
Bliss GVS Pharma 649.00 773.53 729.81 60.26 12.51
Fermenta Biotec. 522.75 474.15 450.25 24.40 18.77
Amrutanjan Healt 501.90 520.13 502.55 26.88 24.16
Guj. Themis Bio. 412.60 152.47 150.80 110.32 27.21
Ambalal Sarabhai 44.79 19.52 3.94 82.94 6.77